Amneal (AMRX) news
Recent news
Trading halt: Aztr (AMEX) - Regulatory concern
On October 13, 2026, trading for Aztr (AMEX) was temporarily suspended amid regulatory concerns, according to reports. While no official statement has been issued by the New York Stock Exchange, the halt has raised questions among investors about the company’s compliance status and operational…
AInvest Wire · 1d agoAmneal announces FDA approval and launch of lanreotide injection
AInvest Wire · Sep 18, 2026Amneal Pharma: Leerink partners initiates coverage with outperform rating; price target $23
AInvest Wire · Sep 9, 2026Amneal Pharma: Selling stockholders may offer & sell from time to time up to 28,942,098 shares of class A common stock - SEC filing
AInvest Wire · Sep 3, 2026FDA: Working with all six estradiol transdermal patch manufacturers to increase supply - Statement
The Food and Drug Administration (FDA) has confirmed it is collaborating with all six manufacturers of estradiol transdermal patches to address rising demand and ensure supply stability. While the FDA has not officially listed estrogen patches as being in shortage, industry stakeholders report…
AInvest Wire · Sep 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.